BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Innovations in Science

We're accelerating the delivery of treatments and cures.

2022 MDA Clinical and Scientific Conference

On behalf of MDA please accept our heartfelt thanks for attending the 2022 MDA Clinical & Scientific Conference.

With the support of our wonderful session chairs and speakers as well as our dedicated conference sponsors we were able to bring you:

  • 1028 in-person attendees from 15 countries
  • 675 virtual live-stream attendees (and counting) from 15 countries
  • 32 Sessions with one full day of clinical trial updates
  • > 120 Speakers
  • > 150 Posters
  • > 30 Exhibitors
  • 10 Industry Forums
  • > 100 Virtual Posters
  • > 40 Virtual Exhibits

Thank you again for your participation and for all your support as we work to transform the lives of people living with muscular dystrophy, ALS, and related neuromuscular diseases.

Conference Platform

Find MDA
in your Community